HOWL
Werewolf Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$0.78
-0.05 ▼ -5.59%
🌙 3월 13일 7:53 PM ET (한국 3/14 08:53)
$0.76
-0.02 ▼ -2.44%
| Index | - | P/E | - | EPS (ttm) | -1.62 | Insider Own | 16.81% | Shs Outstand | 0.05B | Perf Week | 23.41% |
| Market Cap | 0.04B | Forward P/E | - | EPS next Y | 8.8% | Insider Trans | -42.45% | Shs Float | 0.04B | Perf Month | 16.2% |
| Enterprise Value | 0.01B | PEG | - | EPS next Q | -0.34 | Inst Own | 27.98% | Short Float | 5.13% | Perf Quarter | -27.12% |
| Income | -0.07B | P/S | - | EPS this Y | 7.67% | Inst Trans | -1.08% | Short Ratio | 3.25 | Perf Half Y | -45.47% |
| Sales | 0.00B | P/B | 1.24 | EPS next 5Y | 0.72% | ROA | -66.32% | Short Interest | 2.07M | Perf YTD | 23.09% |
| Book/sh | 0.63 | P/C | 0.58 | EPS past 3/5Y | 39.54% -20.76% | ROE | -122.43% | 52W High | -67.24% ($2.38) | Perf Year | -35.55% |
| Cash/sh | 1.35 | P/FCF | - | Sales past 3/5Y | - | ROIC | -122.61% | 52W Low | 47.1% ($0.53) | Perf 3Y | -65.5% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -8.3% | Gross Margin | - | Volatility(W/M) | 14.92% 9.61% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | -100% | Oper. Margin | - | ATR (14) | 0.07 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 3.87 | EPS Q/Q | 6.32% | Profit Margin | - | RSI (14) | 61.28 | Recom | 1.5 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.87 | Sales Q/Q | - | SMA20 | 15.49% ($0.68) | Beta | 0.64 | Target Price | $6 |
| Payout | - | Debt/Eq | 1.26 | Earnings | 11000000 | SMA50 | 19.41% ($0.65) | Rel Volume | 0.47 | Prev Close | $0.83 |
| Employees | 46 | LT Debt/Eq | 1.01 | EPS/Sales Surpr. | 6.08% - | SMA200 | -31.01% ($1.13) | Avg Volume(3M) | 0.64M | Price | $0.78 |
| IPO | 2021/4/30 | Option/Short | Yes/Yes | Trades | 581 | Volume | 300,933 | Change | -5.59% |
뉴스 로딩 중...